Genetic polymorphisms in the estrogen receptor-α gene and the risk of endometrial cancer: A meta-analysis

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 8, 2012, Pages 911-916

  Wang, Yumei ^a   Cui, Meng ^a   Zheng, Liqiang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

cancer susceptibility; Endometrial cancer; endometrium; estrogen receptor ; polymorphism

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ASIAN; AUSTRALIA; CANCER RISK; CANCER SUSCEPTIBILITY; ENDOMETRIUM CANCER; EUROPE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; AUSTRALIA; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 84863903203     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01393.x     Document Type: Review

References (30)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, (eds). Cancer incidence in five continents. Volume VIII. France: IARC Scientific Publications; 2002. pp. 1-781.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M,. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225-49.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893-917.
4. Lindemann K, Vatten LJ, Ellstrøm-Engh M, Eskild A,. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer. 2008; 98: 1582-5. (Pubitemid 351652323)
5. Mulholland HG, Murray LJ, Cardwell CR, Cantwell MM,. Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis. Br J Cancer. 2008; 99: 434-41.
6. Kang S, Roh JW, Kim JW,. Single nucleotide polymorphism: a new risk factor for endometrial cancer? Future Oncol. 2005; 1: 323-30.
7. Pearce ST, Jordan VC,. The biological role of estrogen receptors α and β in cancer. Crit Rev Oncol Hematol. 2004; 50: 3-22. (Pubitemid 38501614)
8. Cowley SM, Hoare S, Mosselman S, Parker MG,. Estrogen receptors α and β form heterodimers on DNA. J Biol Chem. 1997; 272: 19858-62. (Pubitemid 27340081)
9. Castagnoli A, Maestri I, Bernardi F, Del Senno L,. PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res. 1987; 15: 866.
10. Maruyama H, Toji H, Harrington CR, Sasaki K, Izumi Y, Ohnuma T, et al,. Lack of an association of estrogen receptor α gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol. 2000; 57: 236-40. (Pubitemid 30097192)
11. Cancel-Tassin G, Latil A, Rousseau F, Mangin P, Bottius E, Escary JL, et al,. Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk. Eur Urol. 2003; 44: 487-90. (Pubitemid 37185677)
12. González-Zuloeta Ladd AM, Vásques A, Rivadeneira F, Siemes C, Hofman A, Sticker BHCh, et al,. Estrogen receptor α polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat. 2008; 107: 415-9. (Pubitemid 351172114)
13. Gennari L, Merlotti D, De Paola V, Calabrò A, Becherini L, Martini G, et al,. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol. 2005; 161: 307-20. (Pubitemid 40256202)
14. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-88. (Pubitemid 17189972)
15. Lau J, Ioannidis JP, Schmid CH,. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997; 127: 820-6. (Pubitemid 27465551)
16. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-34. (Pubitemid 27387172)
17. Weiderpass E, Persson I, Melhus H, Wedrén S, Kindmark A, Baron JA,. Estrogen receptor α gene polymorphisms and endometrial cancer risk. Carcinogenesis. 2000; 21: 623-7. (Pubitemid 30214016)
18. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R,. Polymorphisms of estrogen receptor alpha gene in endometrial cancer. Biochem Biophys Res Commun. 2002; 297: 558-64.
19. Iwamoto I, Fujino T, Douchi T, Nagata Y,. Association of estrogen receptor alpha and beta3-adrenergic receptor polymorphisms with endometrial cancer. Obstet Gynecol. 2003; 102: 506-11. (Pubitemid 37311212)
20. Shan D, Guo YY, E W., Association between estrogen receptor genetic polymorphisms and endometrial cancer. Chin J Obstet Gynecol. 2003; 38: 576.
21. Wedrén S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvänen AC, et al,. Estrogen receptor alpha gene polymorphism and endometrial cancer risk-a case-control study. BMC Cancer. 2008; 8: 322.
22. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, et al,. Estrogen receptor polymorphisms and the risk of endometrial cancer. BJOG. 2009; 116: 1053-61.
23. Sobczuk A, Smolarz B, Romanowicz-Makowska H, Pertyński T,. Estrogen receptor alpha (ER-alpha) gene polymorphism in patients from the Lodz region of Poland with sporadic endometrial cancer. Eur J Gynaecol Oncol. 2009; 30: 431-4.
24. Yang HP, Gonzalez-Bosquet J, Li Q, Platz EA, Brinton LA, Sherman ME, et al. Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogenesis. 2010; 31: 827-33.
25. Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W,. Hormonal interactions in endometrial cancer. Endocr Relat Cancer. 2000; 7: 227-42. (Pubitemid 32175106)
26. Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA, et al,. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation. 2002; 105: 1879-82. (Pubitemid 34437611)
27. Yaich L, Dupont WD, Cavener DR, Parl FF,. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res. 1992; 52: 77-83.
28. Song F, Sheldon TA, Sutton AJ, Abrams KR, Jones DR,. Methods for exploring heterogeneity in meta-analysis. Eval Health Prof. 2001; 24: 126-51. (Pubitemid 33089375)
29. Fang F, Yu L, Zhong Y, Yao L,. TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis. Med Oncol. 2010; 27: 1324-8.
30. Jiang DK, Yao L, Ren WH, Wang WZ, Peng B, Yu L,. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis. Med Oncol. 2011; 28: 1129-35.